ENPICOM, an innovative bioinformatics software engineering company, has announced it will expand the IGX Platform’s capabilities towards advanced liability prediction. At the Antibody Engineering and Therapeutics virtual conference, the company revealed its plans to integrate the Structural Antibody Prediction Platform (SAbPred) developed by researchers at the University of Oxford. “SAbPred is a widely recognized and […]
Author Archive for: panglobal
This author has yet to write their bio.
Entries by panglobal
CytoSMART Technologies has launched two new fluorescence live-cell imaging systems – the Lux3 FL Duo Kit and the Multi Lux3 FL. The CytoSMART Lux3 FL Duo Kit is a compact and cost-effective imaging system consisting of two fluorescence microscopes, designed for side-by-side comparison of cell cultures. The CytoSMART Multi Lux3 FL fluorescence live-cell imaging system […]
BioChromato has developed an enzyme assay product – the RAPID Tube Plate 600 (TP-600) that is helping deliver outstanding results in in vitro metabolic stability studies. The TP-600 is manufactured from ultra-pure polypropylene that does not contain any enzyme inhibitors such as EDTA or other contaminants that may degrade your assay results. In addition, the […]
Bio-Rad Laboratories has introduced three StarBright dyes designed for flow cytometry applications. StarBright Violet 570, 670, and 710 dyes offer improved brightness and precise excitation and emission spectra, making them suitable for use in multicolour flow cytometry panels. Bio-Rad’s line of StarBright dyes offers researchers a range of fluorescent nanoparticles conjugated to highly validated flow […]
Avacta Group, the developer of diagnostics and innovative cancer therapies based on its proprietary Affimer® and pre|CISION™ platforms, has received notice of registration of its AffiDX® SARS-CoV-2 antigen lateral flow test in the EU allowing the company to market the product in the EU for professional use. Lateral flow antigen tests are intended to provide […]
3Brain AG has introduced a new technology based on a unique combination of microchips and AI that promises to change the way drug candidates are selected at the preclinical level to enter into clinical trials – and to maximize their chances of success. Using CorePlate™ technology, preclinical cell assays are performed in multiwell plates that […]
Takara Bio Europe AB (TBEAB) and PanCryos have reached a licensing agreement surrounding TBEAB’s clinical-grade human embryonic stem (hES) cell lines. PanCryos has established a simplified and effective method to generate stem cell-derived, glucoseresponsive beta cells and is one of several customers in TBEAB’s new out-licensing programme.
SignalChem Lifesciences, a clinical-stage company developing novel targeted therapies for oncology, is collaborating with Merck (MSD) through a subsidiary, to evaluate the combination of SLC-391, a selective AXL inhibitor developed by SignalChem, with KEYTRUDA (pembrolizumab), Merck’s anti-PD-1 therapy, in patients with advanced non-small cell lung cancer (NSCLC).
Phico Therapeutics, a biotechnology company developing engineered phage technology as the basis of a new generation of antibiotics to overcome antibacterial resistance, has been awarded a grant of up to US$18.2 million from Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), a global non-profit partnership dedicated to accelerating antibacterial research.
Viroclinics-DDL, a Contract Research Organization specialized in molecular diagnostic testing and assay development, and ENPICOM, a bioinformatics software engineering company, have received approval of their joint MIT Zuid subsidy (SME Innovation Stimulation Top Sectors South Holland) application. This R&D partnership project combines ‘wet-lab’ (in vitro) diagnostic and high-throughput sequencing expertise of Viroclinics-DDL and ‘dry-lab’ (in […]